Skip to main content
DNA Labs India

SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome NGS Genetic Test

Short Name: SLC19A2 Gene TRMA NGS Test

Also known as: Thiamine-responsive megaloblastic anemia syndrome, TRMA, SLC19A2-related disorder

SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.

Next Generation Sequencing (NGS) Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

To diagnose Thiamine-responsive megaloblastic anemia syndrome by detecting mutations in the SLC19A2 gene, enabling targeted treatment with thiamine supplementation and management of associated symptoms.

Test Code
5633
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

Clinical history of patient and genetic counseling session to draw a pedigree chart of family members affected with TRMA.

Method: Venipuncture or FTA card application

Step 2

Laboratory Analysis

Blood sample collected via venipuncture or one drop on FTA card by a trained phlebotomist.

Step 3

Report Delivery

Sample labeled and transported to the laboratory under appropriate conditions for DNA extraction and analysis.

Timeline: 3 to 4 Weeks

Patient Instructions

1
Before the Test:Genetic counseling and clinical history review are recommended before sample collection.
2
During the Test:Sample collection involves a simple blood draw or FTA card application, typically taking 10-15 minutes.
3
After the Test:Results are available in 3-4 weeks and delivered via online portal, email, or WhatsApp. Follow-up consultation is advised.

About This Test

Who Should Get This Test

To diagnose Thiamine-responsive megaloblastic anemia syndrome by detecting mutations in the SLC19A2 gene, enabling targeted treatment with thiamine supplementation and management of associated symptoms.

How to Prepare

  • Ensure patient identification and consent
  • Use sterile equipment for blood draw
  • For FTA card, apply one drop of blood and air dry
  • Store samples at ambient room temperature

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This genetic test is essential for confirming TRMA diagnosis and initiating thiamine therapy, which can significantly improve patient outcomes by addressing anemia, diabetes, and hearing loss."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Collection MethodVenipuncture or FTA card application

Sample Stability

Blood samples stable for 48 hours at room temperature
Extracted DNA stable for years if stored properly
Sample Rejection Criteria:
  • Insufficient sample volume
  • Hemolyzed or clotted blood
  • Incorrect labeling
  • Contaminated samples

Understanding Your Results

Results indicate the presence or absence of mutations in the SLC19A2 gene. Positive results confirm TRMA diagnosis, while negative results may require further clinical evaluation.
📊

Pathogenic variant detected

Confirms diagnosis of TRMA; recommend thiamine supplementation and multidisciplinary care

📊

Likely pathogenic variant detected

Strong indication of TRMA; genetic counseling and clinical correlation advised

📊

Variant of uncertain significance

Further testing or family studies may be needed; consult geneticist

📊

No pathogenic variants detected

TRMA unlikely based on genetic testing; consider other diagnoses

⚠️ When to Consult a Doctor:

If symptoms of anemia, diabetes, or hearing loss are present, or if there is a family history of TRMA, consult a hematologist or geneticist for evaluation and possible testing.

Limitations

  • May not detect all genetic variants; genetic counseling is recommended
  • Results should be correlated with clinical findings
  • Does not rule out other genetic disorders

Risks & Considerations

  • Minor bruising or pain at the needle site
  • Rare risk of infection
  • No significant risks associated with genetic testing itself

Interfering Factors

  • Sample contamination
  • Degraded DNA
  • Incorrect sample type

Frequently Asked Questions

What is Thiamine-responsive megaloblastic anemia syndrome (TRMA)?
TRMA is a rare inherited disorder caused by mutations in the SLC19A2 gene, leading to anemia, diabetes, and hearing loss due to impaired thiamine transport.
What are the symptoms of TRMA?
Symptoms include megaloblastic anemia, fatigue, shortness of breath, enlarged liver and spleen, diabetes mellitus, and sensorineural hearing loss, often appearing in childhood.
How is TRMA diagnosed?
TRMA is diagnosed through genetic testing, specifically Next Generation Sequencing (NGS) of the SLC19A2 gene to identify causative mutations.
What is the cost of the SLC19A2 Gene TRMA NGS Genetic Test?
The test costs INR 20000 at DNA Labs India, with home sample collection available across India.
What sample is required for this test?
The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Is fasting required before the test?
No, fasting is not required for this genetic test.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after sample collection.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for this test in numerous cities across India.
What should I do if I have a family history of TRMA?
Consult a geneticist or hematologist for evaluation and consider genetic testing for early diagnosis and management.
Can TRMA be treated?
Yes, TRMA is responsive to high-dose thiamine supplementation, which can improve anemia, diabetes control, and potentially hearing loss.
Is this test covered by insurance?
Coverage varies by insurance scheme; it is not typically covered under government schemes like PMJAY or CGHS, but check with your provider.
What are the limitations of this test?
The test may not detect all genetic variants, and results should be interpreted with clinical correlation and genetic counseling.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.